Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 05 Oct 2021 for OptimizeRx Corp, €291k. Read the official filing
Filing timeline
BuySaleDouglas P. Baker
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Douglas P. Baker: trading record in brief
This profile gathers the share dealings of Douglas P. Baker in OptimizeRx Corp, where the filings describe the role as finance chief. The record holds 17 filings, for trades running from 18 May 2021 to 5 October 2021.
No open-market purchase appears, only 17 sales worth €4.8M.
On 5 October 2021 came the latest disclosure, an open-market sale for €291k in OptimizeRx Corp. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Douglas P. Baker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
4,000 shares@ US$84.226.0% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-051449:0
2,000 shares@ US$74.662.6% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-050600:0
4,000 shares@ US$70.595.0% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-049366:0
3,768 shares@ US$65.574.3% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-048250:0
2,232 shares@ US$70.532.7% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-047223:0
4,000 shares@ US$66.624.7% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-046409:0
5,000 shares@ US$58.455.2% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-044609:0
5,000 shares@ US$63.275.6% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-043479:0
10,000 shares@ US$64.3111.3% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-041400:0
2,000 shares@ US$54.931.9% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-040133:0
3,000 shares@ US$52.582.8% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-039109:0
3,000 shares@ US$50.902.7% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-037938:0
13,435 shares@ US$56.0513.1% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-036374:0
3,421 shares@ US$63.003.7% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-035072:0
4,000 shares@ US$60.004.2% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-034239:0
14,500 shares@ US$52.6212.9% of flowCommon Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-031479:0
14,500 shares@ US$45.8511.2% of flowCommon StockSEC:0001213900-21-027935:0
17 of 17 declarations
